Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus‐related hepatocellular carcinoma
- 11 November 2024
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 86 (4) , 547-558
Abstract
Aims: The frequency of CTNNB1 mutation, one of the most frequent genetic events in hepatocellular carcinoma (HCC), is lower in Asian countries and in hepatitis B virus (HBV)‐related HCCs. In this study, we evaluated the prevalence and types of CTNNB1‐mutation in HBV‐related HCC and correlated the molecular status with the histomorphological and immunohistochemical features.Methods and results: A total of 108 consecutive cases of treatment‐naïve, surgically resected HBV‐related HCCs were selected. Targeted sequencing for CTNNB1 exons 3, 7 and 8 was performed, and the results were correlated with the expression pattern of glutamine synthetase (GS), nuclear β‐catenin expression status and the histomorphological characteristics of the tumour. CTNNB1 mutations were identified in 13% of HBV‐related HCCs; of these cases, mutations were found in D32‐S37 (7%), T41 (4%) and S45 (2%) of exon 3. None of the HCCs demonstrated alterations in exons 7 and 8. CTNNB1 mutation was strongly associated with diffuse strong GS expression (P < 0.001), nuclear β‐catenin expression (P < 0.001) and the classic CTNNB1 morphology (P = 0.038). Diffuse strong GS expression was observed in 78.6% of the CTNNB1‐mutated HCCs, and nuclear β‐catenin expression was identified in 64.3% of these cases. The classic CTNNB1 morphology was observed in 57% of all CTNNB1‐mutated HCCs. Furthermore, programmed death‐ligand 1 (PD‐L1) was less frequently expressed in HCCs with classic CTNNB1 morphology.Conclusions: CTNNB1 mutation was observed in 13% of HBV‐related HCCs in this Korean cohort, and was associated with diffuse strong GS expression, nuclear β‐catenin expression and classic CTNNB1 morphology.Keywords
This publication has 38 references indexed in Scilit:
- Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironmentsHepatology, 2021
- Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular CarcinomaHepatology, 2019
- Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinomaJournal of Gastroenterology, 2016
- Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progressionHepatology, 2016
- A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial–mesenchymal transition–independent mannerHepatology, 2015
- Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratificationHepatology, 2014
- Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signalingCancer Letters, 2011
- Regulation of the expression balance of angiopoietin-1 and angiopoietin-2 by Shh and FGF-2In Vitro Cellular & Developmental Biology - Animal, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Unique phenotype of hepatocellular cancers with exon‐3 mutations in beta‐catenin gene†Hepatology, 2009